Labeled for this condition
Medicines for urinary tract infections
39 medicines have an FDA label indicated for urinary tract infections; 28 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for urinary tract infections?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Doxycycline | Oracea, Acticlate, Doryx | 83 labelers | $0.118 per tablet 100 mg tablet | No | A presentation being discontinued | 19 |
| Amoxicillin and clavulanate | Augmentin | 31 labelers | $0.0693 per mL 600-42.9 mg/5 mL sus | No | No current entry | 5 |
| Ciprofloxacin | Cipro, Ciloxan | 54 labelers | $0.123 per tablet 500 mg tablet | Yes | No current entry | 14 |
| Cephalexin | none listed | 35 labelers | $0.120 per capsule 500 mg capsule | No | No current entry | 22 |
| Fluconazole | Diflucan | 41 labelers | $0.380 per tablet 200 mg tablet | No | No current entry | 18 |
| Nitrofurantoin | Macrobid | 47 labelers | $0.165 per capsule 50 mg capsule | No | A presentation being discontinued | 13 |
| Minocycline | Emrosi, Amzeeq, Zilxi | 21 labelers | $0.343 per capsule 100 mg capsule | No | No current entry | 3 |
| Levofloxacin | none listed | 44 labelers | $0.259 per tablet 750 mg tablet | Yes | No current entry | 13 |
| Phenazopyridine | none listed | none listed | $0.154 per tablet 100 mg tablet | No | No current entry | 4 |
| Sulfamethoxazole and trimethoprim | Sulfatrim, Bactrim, Sulfamethox-Tmp | 44 labelers | $0.0448 per tablet Sulfamethoxazole-tmp ds tablet | No | No current entry | 12 |
| Ampicillin | none listed | 17 labelers | $0.441 per capsule 500 mg capsule | No | A presentation being discontinued | 3 |
| Tobramycin | Tobi, Tobrex, Kitabis | 40 labelers | $1.08 per mL 300 mg/5 mL ampule | No | A presentation being discontinued | 8 |
| Ceftriaxone | none listed | 16 labelers | $1.44 per vial 1 g vial | No | No current entry | 20 |
| Cefuroxime | none listed | 19 labelers | $0.280 per tablet 250 mg tablet | No | No current entry | 1 |
| Cefazolin | none listed | 15 labelers | $1.07 per vial 1 g vial | No | No current entry | 10 |
| Cefadroxil | none listed | 19 labelers | $0.269 per capsule 500 mg capsule | No | No current entry | 0 |
| Cefepime | none listed | 8 labelers | n/a | No | A presentation being discontinued | 10 |
| Ertapenem | Invanz | 15 labelers | $26.63 per vial 1 gram vial | No | No current entry | 0 |
| Cefoxitin | none listed | 5 labelers | n/a | No | No current entry | 1 |
| Cefixime | none listed | 6 labelers | $10.03 per capsule 400 mg capsule | No | No current entry | 8 |
| Fosfomycin | Contepo | 10 labelers | $26.22 per unit 3 g sachet | No | No current entry | 2 |
| Methenamine | none listed | 10 labelers | $0.313 per tablet 1 g tablet | No | No current entry | 0 |
| Demeclocycline | none listed | 5 labelers | $2.27 per tablet 150 mg tablet | No | No current entry | 0 |
| Polymyxin b | none listed | 7 labelers | n/a | Yes | No current entry | 1 |
| Cilastatin and imipenem | Primaxin | 2 labelers | n/a | No | A presentation being discontinued | 0 |
| Cefotetan | none listed | 2 labelers | n/a | No | No current entry | 0 |
| Trimethoprim | none listed | 4 labelers | $1.31 per tablet 100 mg tablet | No | No current entry | 0 |
| Plazomicin | Zemdri | none listed | n/a | Yes | No current entry | 0 |
| Sulfadiazine | none listed | 2 labelers | $15.06 per tablet 500 mg tablet | No | No current entry | 0 |
| Avibactam and ceftazidime | Avycaz | none listed | n/a | No | No current entry | 0 |
| Cefepime and zidebactam | Zaynich | none listed | n/a | No | No current entry | 0 |
| Cefiderocol | Fetroja | none listed | n/a | No | No current entry | 0 |
| Ceftolozane and tazobactam | Zerbaxa | none listed | n/a | No | No current entry | 1 |
| Cilastatin and imipenem and relebactam | Recarbrio | none listed | n/a | No | A presentation being discontinued | 0 |
| Cycloserine | none listed | 1 labeler | n/a | No | No current entry | 0 |
| Gepotidacin | Blujepa | none listed | $91.40 per tablet 750 mg tablet | No | No current entry | 0 |
| Meropenem and vaborbactam | Vabomere | none listed | n/a | No | No current entry | 0 |
| Pivmecillinam | Pivya | none listed | n/a | No | No current entry | 0 |
| Probenecid and sulopenem etzadroxil | Orlynvah | none listed | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price